Strategies for the development of conotoxins as new therapeutic leads.

作者: Ryan Brady , Jonathan Baell , Raymond Norton

DOI: 10.3390/MD11072293

关键词:

摘要: Peptide toxins typically bind to their target ion channels or receptors with high potency and selectivity, making them attractive leads for therapeutic development. In some cases the native peptide as it is found in venom from which originates can be used directly, but many instances desirable truncate and/or stabilize improve its properties. A complementary strategy display key residues that make up pharmacophore of toxin on a non-peptidic scaffold, thereby creating peptidomimetic. This review exemplifies these approaches marine organisms, particular focus conotoxins.

参考文章(119)
Susan J. Allison, An oral cyclic peptide drug to reverse kidney fibrosis? Nature Reviews Nephrology. ,vol. 8, pp. 193- 193 ,(2012) , 10.1038/NRNEPH.2012.26
Josias H Hamman, Gill M Enslin, Awie F Kotz??, Oral delivery of peptide drugs: barriers and developments. BioDrugs. ,vol. 19, pp. 165- 177 ,(2005) , 10.2165/00063030-200519030-00003
J.M. McIntosh, D. Yoshikami, E. Mahe, D.B. Nielsen, J.E. Rivier, W.R. Gray, B.M. Olivera, A nicotinic acetylcholine receptor ligand of unique specificity, alpha-conotoxin ImI. Journal of Biological Chemistry. ,vol. 269, pp. 16733- 16739 ,(1994) , 10.1016/S0021-9258(19)89452-8
Keith K. Khoo, Raymond S. Norton, Role of Disulfide Bonds in Peptide and Protein Conformation Amino Acids, Peptides and Proteins in Organic Chemistry. pp. 395- 417 ,(2011) , 10.1002/9783527631841.CH11
Jonathan B. Baell, Stewart A. Forsyth, Robert W. Gable, Raymond S. Norton, Roger J. Mulder, Design and synthesis of type-III mimetics of ω-conotoxin GVIA Journal of Computer-aided Molecular Design. ,vol. 15, pp. 1119- 1136 ,(2001) , 10.1023/A:1015930031890
Bianca J. van Lierop, Christoph Bornschein, W. Roy Jackson, Andrea J. Robinson, Ring-closing Metathesis in Peptides – the Sting is in the Tail! Australian Journal of Chemistry. ,vol. 64, pp. 806- 811 ,(2011) , 10.1071/CH11090
James P. Flinn, Paul K. Pallaghy, Michael J. Lew, Roger Murphy, James A. Angus, Raymond S. Norton, Roles of key functional groups in omega-conotoxin GVIA synthesis, structure and functional assay of selected peptide analogues. FEBS Journal. ,vol. 262, pp. 447- 455 ,(1999) , 10.1046/J.1432-1327.1999.00383.X
Andreas Brust, Elka Palant, Daniel E. Croker, Barbara Colless, Roger Drinkwater, Brad Patterson, Christina I. Schroeder, David Wilson, Carsten K. Nielsen, Maree T. Smith, Dianne Alewood, Paul F. Alewood, Richard J. Lewis, chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. Journal of Medicinal Chemistry. ,vol. 52, pp. 6991- 7002 ,(2009) , 10.1021/JM9003413
B. Callaghan, A. Haythornthwaite, G. Berecki, R. J. Clark, D. J. Craik, D. J. Adams, Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. The Journal of Neuroscience. ,vol. 28, pp. 10943- 10951 ,(2008) , 10.1523/JNEUROSCI.3594-08.2008
Richard Layer, J. McIntosh, Conotoxins: Therapeutic Potential and Application Marine Drugs. ,vol. 4, pp. 119- 142 ,(2006) , 10.3390/MD403119